DataSet Record GDS3396: Expression Profiles Data Analysis Tools Sample Subsets
Title: Rosiglitazone effect on kidneys
Cluster AnalysisGDS3396 Cluster Image
Summary: Analysis of kidneys from lean and obese animals fed a diet supplemented with rosiglitazone for 12 weeks. Rosiglitazone is a thiazolidinedione drug used to treat diabetes. Results provide insight into the mechanism of action of rosiglitazone.
Organism: Rattus norvegicus
Platform: GPL1355: [Rat230_2] Affymetrix Rat Genome 230 2.0 Array
  • Song J, Liu H, Ressom HW, Tiwari S et al. Chronic rosiglitazone therapy normalizes expression of ACE1, SCD1 and other genes in the kidney of obese Zucker rats as determined by microarray analysis. Exp Clin Endocrinol Diabetes 2008 Jun;116(6):315-25. PMID: 18700276
Reference Series: GSE7193 Sample count: 12
Value type: count Series published: 2008/03/04